Hu et al. conducted a meta‐analysis and found that PDPN‐positive CAFs were associated with poor prognosis in cholangiocarcinoma, breast cancer, NSCLC, and pancreatic cancer.19 This evidence concerns the gene PDPN and non-small cell lung carcinoma.